Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest & Investment Income (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Interest & Investment Income for 4 consecutive years, with $1088.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 51.17% to $1088.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $7724.0, a 69.95% decrease, with the full-year FY2024 number at $17610.0, down 85.58% from a year prior.
  • Interest & Investment Income was $1088.0 for Q3 2025 at bioAffinity Technologies, down from $2025.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $44124.0 in Q2 2023 to a low of $3.0 in Q3 2022.
  • A 4-year average of $13988.2 and a median of $5186.0 in 2024 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 906333.33% in 2023, then crashed 91.81% in 2024.
  • bioAffinity Technologies' Interest & Investment Income stood at $38447.0 in 2022, then plummeted by 68.37% to $12160.0 in 2023, then plummeted by 66.54% to $4069.0 in 2024, then plummeted by 73.26% to $1088.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Interest & Investment Income are $1088.0 (Q3 2025), $2025.0 (Q2 2025), and $542.0 (Q1 2025).